Summit Global Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.58M	Sell	9,804 -18	-0.2%	-$13.8K	0.45%	33
2025 Q4	$7.58M	Sell	9,822 -9,801	-50%	-$6.66M	0.45%	26
2025 Q3	$11M	Buy	+19,623	New	+$11.1M	0.64%	26
2025 Q2	–	Sell	-2,772	Closed	-$1.76M	–	513
2025 Q1	$1.76M	Sell	2,772 -7,342	-73%	-$5.05M	0.13%	97
2024 Q4	$7.21M	Sell	10,114 -1,754	-15%	-$1.47M	0.45%	51
2024 Q3	$12.5M	Buy	11,868 +2,195	+23%	+$2.44M	0.8%	27
2024 Q2	$10.2M	Sell	9,673 -2,651	-22%	-$2.57M	0.69%	33
2024 Q1	$11.9M	Sell	12,324 -3,915	-24%	-$3.72M	0.88%	29
2023 Q4	$14.3M	Buy	16,239 +15,931	+5,172%	+$13.1M	0.93%	21
2023 Q3	$254K	Buy	308 +8	+3%	+$6.29K	0.02%	453
2023 Q2	$216K	Buy	+300	New	+$231K	0.01%	499
2021 Q4	–	Sell	-18,835	Closed	-$11.4M	–	594
2021 Q3	$11.4M	Buy	18,835 +2,535	+16%	+$1.57M	0.85%	31
2021 Q2	$9.09M	Buy	16,300 +713	+5%	+$361K	0.54%	36
2021 Q1	$7.38M	Buy	15,587 +14,779	+1,829%	+$7.2M	0.47%	50
2020 Q4	$390K	Buy	808 +207	+34%	+$112K	0.04%	216
2020 Q3	$336K	Buy	+601	New	+$364K	0.03%	213